Regeneron
Regeneron

Regeneron and FUJIFILM Ink $3B Manufacturing Deal!
BIOT
Exciting news! 🎉 FUJIFILM Diosynth and Regeneron sign a 10-year, $3+ billion deal to boost U.S. biologic medicine production! 🏭💼

Regeneron Cuts Costs by Streamlining AAV Production!
BIOT
**Excerpt:** Regeneron revolutionizes AAV manufacturing by eliminating endonuclease! 🌟 Save up to $100,000 per batch while enhancing efficiency! 💰🔬⚙️

Regeneron Joins Forces with 2seventy for Breakthrough Cancer Treatments
BIOT
Regeneron partners with 2seventy to boost cell therapy pipeline 🤝💼. Aims to develop immune cell therapies for cancer treatment 🧪🔍.






